Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOndo Insurtech Regulatory News (ONDO)

Share Price Information for Ondo Insurtech (ONDO)

Share Price is delayed by 15 minutes
Get Live Data
3.40    0.00 (0.00%)
Bid:
3.30
Ask:
3.50
Spread: 0.20 (6.061%)
Market Cap: £5.09m
ONDO Live PriceLast checked at - London Stock Exchange

Intraday Ondo Insurtech Share Chart

Directorate Change

4 Aug 2025 07:00

RNS Number : 7295T
Ondo InsurTech PLC
04 August 2025
 

4 August 2025

Ondo InsurTech Plc

("Ondo" or the "Company")

 

 

Board Changes

 

 

Ondo InsurTech Plc (LSE: ONDO), a leading provider of claims prevention technology for home insurers, is pleased to announce the appointment of James Quin and Greig Paterson to the Board of Directors of the Company. James Quin will serve as Senior Independent Director of the Company and as Chair of the Audit and Risk Committee, with effect from 1 August 2025. Greig Paterson will serve as Non-Executive Director of the Company, with effect from 1 August 2025.

 

The Company also announces the resignation of Andy Morrison as Non-Executive Director of the Company with effect from 31 July 2025. Andy was a director of the Company at the time of the reverse takeover of LeakBot Limited in 2021. Andy owns 3,750,000 Ondo shares, representing 2.7% of the Company's issued share capital. Andy also holds 200,000 warrants which are to be exercised on or before 22 May 2026.

 

James Quin is an accomplished C-suite executive with over 30 years' experience in the insurance sector, including financial management, strategy, regulation, and investor relations. He has held senior executive positions at Saga, Zurich, and Citigroup, and brings a broad range of leadership experience across the industry. James currently serves as Non-Executive Director and Audit Committee Chair at Policy Expert and Thomas Miller Holdings, two privately held companies operating in the insurance sector.

 

James is a Fellow of the Institute of Chartered Accountants in England and Wales and began his career in the insurance division of PricewaterhouseCoopers in 1990. He then moved into equity research with several investment banks including Lehman Brothers, HSBC, and Citigroup, where he held the role of Managing Director and Head of European Insurance Equity Research. From 2013-2018, James held various roles with Zurich Insurance Group, and from 2019-2024 he was Group CFO and an Executive Director of London listed Saga Plc.

 

Greig Paterson is a Fellow of the Faculty of Actuaries and Chartered Financial Analyst, who brings 30 years of experience in financial services, with deep expertise in insurance, capital markets, and strategic advisory. He currently advises Nordic Capital on sector strategy, financial modelling, and due diligence in financial services, including fintech. From 2024 to 2025, he worked independently, providing strategic and M&A advice to several large private equity firms. He is also a member of the IFRS and ISSB Advisory Councils.

 

Previously, Greig spent nearly two decades at Keefe, Bruyette & Woods (KBW), where he was a Managing Director of European Research. A founding member of KBW's London office, he led coverage of UK and Asian life and non-life insurers and was a highly-ranked analyst in external surveys. He played a key role as syndicate member analyst in several major IPOs including Direct Line, Hastings Insurance, AIA, Just Retirement, Partnership Assurance, and PensionBee, and so was instrumental in developing KBW's primary capital markets offering in Europe. Earlier in his career, he held analyst and actuarial roles at Fox-Pitt Kelton, UBS, and Norwich Life South Africa.

 

Mark Wood, Chairman, commented :

 

On behalf of the Board, I would like to extend our gratitude to Andy for his personal commitment, invaluable expertise, and clear emphasis on excellence. Andy's guidance and steadfast support have been instrumental in driving Ondo's strong growth over the past three years since the RTO and we wish him continued success in all his future endeavours.

 

I am pleased to welcome James Quin and Greig Paterson to the Board as Independent Non-Executive Directors. James brings a wealth of financial and regulatory expertise from senior leadership roles across the insurance sector, including his recent position as Group CFO of Saga Plc. Greig offers deep insight into capital markets, sector strategy, and investor engagement, having spent over two decades as a highly ranked insurance analyst. Their appointments strengthen the Board's financial and strategic capabilities and underline our commitment to strong governance as we execute our growth strategy and continue to build long-term shareholder value.

 

 

There are no further regulatory disclosures with regards to the appointment of James Quin or Greig Paterson to the Board which require disclosure under Listing Rule 6.4.8.

 

 

For further information, please visit www.ondoplc.com or contact the following:

 

Ondo InsurTech Plc

Craig Foster, CEO

Kevin Withington, CFO

+44 (0) 800 783 9866

Dowgate Capital Ltd

(Broker & Financial Advisor)

Russell Cook

Charlie Hall

Amber Higgs

+44 (0) 20 3903 7715

 

Cassiopeia Services Ltd

(PR & Investor Relations)

Stefania Barbaglio

+44 (0) 7949 690338

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGLGDIDUGDGUX
Date   Source Headline
2nd Jun 20265:56 pmRNSShare Incentive Plan Purchase
28th May 20267:00 amRNSVendor Loan Note Restructuring
21st May 20267:00 amRNSAppointment of Non-Executive Director
6th May 20267:00 amRNSShare Incentive Plan Purchase
23rd Apr 202611:01 amRNSChange of Board Responsibilities
21st Apr 20263:30 pmRNSTrading Update for the Year Ended 31 March 2026
13th Apr 20267:00 amRNS-RAlm. Brand Group Extends LeakBot Programme
13th Apr 20267:00 amRNSBoard Changes
8th Apr 202610:59 amRNSShare Incentive Plan Purchase
4th Mar 20265:19 pmRNSShare Incentive Plan Purchase
4th Mar 20267:00 amRNSOndo Extends Contract with Selective Insurance
12th Feb 20267:00 amRNSU.S. Contract Win
9th Feb 20267:00 amRNSAlm. Brand Group to roll out LeakBot
30th Jan 20264:50 pmRNSBlock Listing Update - Warrant Plan
30th Jan 20262:01 pmRNSBlock Listing Update - Option Plan
30th Jan 20262:00 pmRNSDirector/PDMR Shareholding
14th Jan 20267:00 amRNSAppointment of Joint Corporate Broker
2nd Jan 20264:45 pmRNSDirector/PDMR Shareholding
31st Dec 20257:00 amRNSTotal Voting Rights
31st Dec 20257:00 amRNSTotal Voting Rights
17th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20259:50 amRNSHolding(s) in Company
9th Dec 20257:00 amRNSIssue of Equity - Result of WRAP Retail Offer
5th Dec 20253:21 pmRNSUpdate to Placing and Admission
4th Dec 20257:50 amRNSLaunch of WRAP Retail Offer
4th Dec 20257:00 amRNSResult of ABB
3rd Dec 20257:00 amRNSPlacing and Subscription via ABB
3rd Dec 20257:00 amRNSHalf-year Financial Report
1st Dec 20257:00 amRNSChange of Registered Office
27th Nov 20253:33 pmRNSHolding(s) in Company
24th Nov 20257:00 amRNSNotice of Results
24th Nov 20257:00 amRNSContract
19th Nov 20257:00 amRNSContract Win
10th Nov 20257:00 amRNSContract Win
3rd Nov 20255:01 pmRNSDirector/PDMR Shareholding
31st Oct 20257:00 amRNSTotal Voting Rights
9th Oct 202510:46 amRNSDirector/PDMR Shareholding
30th Sep 20254:58 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSTotal Voting Rights
22nd Sep 20254:08 pmRNSResult of AGM
22nd Sep 20257:00 amRNSAGM Statement
4th Sep 20253:30 pmRNSDirector/PDMR Shareholding
3rd Sep 20257:00 amRNSContract
26th Aug 20257:00 amRNS-RTopdanmark agreement update
15th Aug 20253:00 pmRNSNotice of AGM
4th Aug 20254:47 pmRNSHolding(s) in Company
4th Aug 20253:10 pmRNSHolding(s) in Company
4th Aug 20257:00 amRNSDirectorate Change
1st Aug 20251:32 pmRNSDirector/PDMR Shareholding
1st Aug 20259:03 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.